Scientific Publications AAIC 2022 (July 31-August 4)

August 4, 2022 – Alzheimer’s Association International Conference (Moebius et al)

Phase II Drug Development for Alzheimer’s Disease Panel Presentation: Athira Pharma

August 3, 2022 – Alzheimer’s Association International Conference (Moebius et al)

ACT-AD: Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease – First Results of a Randomized, Placebo-Controlled, 26-Week, Phase 2 Proof-of-Concept Trial

Watch Video Presentation

August 2, 2022 – Alzheimer’s Association International Conference (Reda et al)

Fosgonimeton, a Novel, Small-Molecule Positive Modulator of the HGF/MET System, is Neuroprotective in Primary Neuron Culture

Supplemental information to Reda et al, Fosgonimeton, a Novel, Small-Molecule Positive Modulator of the HGF/MET System, is Neuroprotective in Primary Neuron Culture, AAIC Annual Meeting 2022

AthiraPharma · Reda et al. 2022 AAIC e-Poster 65874

July 31, 2022 – Alzheimer’s Association International Conference (Taylor et al)

Development of Stable, Orally Bioavailable, Small-Molecule Positive Modulators of HGF/MET Signaling for the Treatment of Cognitive Impairment

Supplemental information to Taylor et al, Development of Stable, Orally Bioavailable, Small-Molecule Positive Modulators of HGF/MET Signaling for the Treatment of Cognitive Impairment, AAIC Annual Conference 2022

AthiraPharma · Taylor et al. 2022 AAIC e-Poster 63440